This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Kannel WB, Ho K, Thom T (1994) Changing epidemiological features of cardiac failure. Br Heart J 72(Suppl 2):S3–S9
Eriksson H, Svardsudd K, Larsson B et al (1989) Risk factors for heart failure in the general population: the study of men born in 1913. Eur Heart J 10:647–656
The SOLVD Investigators (1991) Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 325:293–302
CONSENSUS trial study group (1987) Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study. N Engl J Med 316:1429–1434
MERIT-HF study group (1999) Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL randomized intervention trial in congestive heart failure (MERIT-HF). Lancet 353:2001–2007
Packer M, Carver JR, Rodeheffer RJ et al (1991) Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group. N Engl Med 325:1468–1475
Ryden-Bergsten T, Andersson F (1999) The health care costs of heart failure in Sweden. J Intern Med 246:275–284
McMurray JHW, Rhodes G (1993) An evaluation of the cost of heart failure to the National Health Service in the UK. Br J Med Econ 6:99–100
Goldman S, Johnson G, Cohn JN et al (1993) Mechanism of death in heart failure. The Vasodilator-Heart Failure Trials. The V-HeFT VA Cooperative Studies Group. Circulation 87(Suppl 6):I24–I31
Xiao HB, Roy C, Gibson DG (1994) Nature of ventricular activation in patients with dilated cardiomyopathy: evidence for bilateral bundle branch block. Br Heart 72:167–174
Cazeau S, Leclercq C, Lavergne T et al (2001) Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med 344:873–880
Abraham WT, Fisher WG, Smith AL et al for the Miracle Study Group (2002) Cardiac resynchronisation in chronic heart failure. N Engl J Med 346:1845–1853
Bristow MR, Saxon LA, Boehmer J et al (2004) Cardiac resynchronisation therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 350:2140–2150
Braunschweig F, Linde C, Gadler F et al (2000) Reduction of hospital days by biventricular pacing. Eur J Heart Fail 2:399–406
Dixon LJ, Murtagh GJ, Rechardson SG et al (2004) Reduction in hospitalisation rates following cardiac resynchronisation therapy in cardiac failure: experience from a single center. Europace 6:586–589
Cline CM, Israelsson BY, Willenheimer RB et al (1998) Cost effective management programme for heart failure reduces hospitalization. Heart 80:442–446
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer-Verlag Italia
About this paper
Cite this paper
Seidl, K. (2005). Economic Benefits of Cardiac Resynchronisation Therapy. In: Gulizia, M.M. (eds) Emerging Pathologies in Cardiology. Springer, Milano . https://doi.org/10.1007/88-470-0341-5_24
Download citation
DOI: https://doi.org/10.1007/88-470-0341-5_24
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-0311-8
Online ISBN: 978-88-470-0341-5
eBook Packages: MedicineMedicine (R0)